Latest News

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

We wouldn't blame UMB Financial Corporation ( NASDAQ:UMBF ) shareholders if they were a little worried about the fact...

Viewing insider transactions for Equillium, Inc.'s ( NASDAQ:EQ ) over the last year, we see that insiders were net...

Plaza S.A. ( SNSE:MALLPLAZA ), is not the largest company out there, but it saw significant share price movement during...

ASML Holding (NasdaqGS:ASML) stock has recently drawn attention after a series of strong trailing returns, with the shares up 3.5% in the past day and 7.7% over the past week. See our latest analysis for ASML Holding. At a share price of $1,867.83, ASML Holding sits on strong recent momentum, with a 30 day share price return of 26.86% and a 1 year total shareholder return of 146.87%. This suggests investors have recently been willing to pay more for its earnings and growth profile. If you are...

Descartes Systems Group (TSX:DSG) is in focus after New Castle Building Products reported cutting annual fleet mileage by about 25,000 miles by using the company’s route planning and execution software. See our latest analysis for Descartes Systems Group. For context, Descartes Systems Group’s share price is at CA$99.18, with a 1 month share price return of 6.46% but a year to date share price decline of 15.20% and a 1 year total shareholder return decline of 26.86%. This suggests that recent...

Cochlear Limited recently downgraded its 2026 earnings guidance, a move that has already influenced sentiment toward premium medical device companies across the ASX healthcare sector. This shift comes as the global ear health market, worth about US$10.12 billion in 2025, is projected to expand meaningfully over the coming decade, underscoring the contrast between long-term industry growth and near-term earnings uncertainty for Cochlear. With Cochlear’s guidance downgrade resetting...

Penny stocks attract attention when markets are shaped by central banks adjusting interest rate paths, shifting current account positions across regions, and mixed signals from consumer data. The Financially Fit Penny Stocks screener focuses on companies trading below 5 that pair this low entry price with an emphasis on financial health. For investors who want exposure to earlier stage opportunities while trying to keep an eye on balance sheet quality, this can be a useful starting point...

Lewis Hamilton recently claimed his first Formula 1 Grand Prix victory for Ferrari at the Barcelona-Catalunya circuit, ending Mercedes' winning run this season and marking Ferrari's first race win since 2024 through a well-executed three-stop strategy and timely virtual safety car pit stop. This breakthrough win, underpinned by recent car upgrades and calm messaging from team principal Fred Vasseur, reinforces Ferrari’s racing pedigree at a time when the company is also pushing into...

Voltalia (ENXTPA:VLTSA) is back in focus after signing a Transmission System Use Agreement with Brazil’s National Electric System Operator. The agreement secures 322 megawatts of grid capacity at the Pecém Industrial and Port Complex. See our latest analysis for Voltalia. Set against this new Brazil grid agreement, Voltalia’s recent 7 day share price return of down 10.05% at €6.89 and a 1 year total shareholder return of down 20.25% point to weaker momentum after a mixed quarter. If you are...

CONMED Corporation has announced that John E. Gallagher will become Chief Financial Officer on July 15, 2026, succeeding Todd Garner, who will stay on as an advisor until November 2, 2026. This leadership transition brings nearly three decades of healthcare-focused financial experience into CONMED’s C-suite, potentially influencing capital allocation, cost discipline, and support for its minimally invasive surgery portfolio. We’ll now examine how bringing in an experienced healthcare CFO...

Earlier this week, FMC Corporation and Corteva, Inc. announced a co-exclusive supply and license agreement giving Corteva access to FMC’s rimisoxafen herbicide technology for corn and soybean markets across North and South America, including an initial US$200,000,000 prepurchase commitment. This agreement broadens Corteva’s weed-control toolkit with a differentiated active ingredient targeting resistant species, potentially reinforcing its crop protection franchise alongside ongoing...

Board Expansion and New Director Appointment Shake Shack (SHAK) is drawing investor attention after two corporate updates, including an upcoming Calgary Stampede debut and a boardroom change that adds experienced consumer executive Christiane Pendarvis as an independent director. The board has approved an expansion from eight to nine members and appointed Pendarvis as a Class II director, effective July 2, 2026, with a term running until the 2029 Annual Meeting of Stockholders. She will sit...

DENTSPLY SIRONA (XRAY) is back in focus after the company appointed John C. Fortson as Chief Financial Officer and Executive Vice President, a leadership change that could influence how investors view the stock. See our latest analysis for DENTSPLY SIRONA. The latest leadership news arrives after a tough stretch for DENTSPLY SIRONA. The share price is down 11% year to date and the 1 year total shareholder return has fallen 32.4%, pointing to fading momentum despite a modest 2.1% 1 month share...

Siltronic (XTRA:WAF) has completed a follow on equity offering, raising €273 million through the sale of 3,000,000 ordinary registered shares at €91 each in a subsequent direct listing, a financing move that may change investor exposure. See our latest analysis for Siltronic. Siltronic’s latest share price of €92.50 comes after a 7 day share price return of 8.19% and a 90 day share price return of 66.07%. The 1 year total shareholder return of 147.59% contrasts with a 5 year total shareholder...

In recent weeks, Hercules Capital has faced an investor lawsuit alleging overstated due diligence and portfolio valuations, even as it amended a senior secured term loan facility with Dyne Therapeutics to provide up to US$125.00 million in additional borrowing capacity. This combination of legal scrutiny and expanded lending activity highlights the tension between questions over past disclosures and the company’s ongoing role as a key non-bank lender to high-growth sectors. Against this...

Some Argan, Inc. ( NYSE:AGX ) shareholders may be a little concerned to see that the Director, William Griffin...

Global banks tied into China’s yuan push are suddenly in focus as panda bond issuance hits record levels and Beijing relaxes capital controls. With foreign borrowers turning to cheaper yuan funding and new channels opening for cross border liquidity, some stocks could see stronger demand for RMB services, while others face policy or currency risks. This article looks at 3 stocks from the Global Banks With High Exposure to Yuan Internationalization Tailwinds screener that are directly exposed...

Compañía de Minas BuenaventuraA (BVN) stock has drawn attention after a one day decline of 4.8%, contrasting with gains over the past week, month, and past 3 months that keep longer term returns elevated. See our latest analysis for Compañía de Minas BuenaventuraA. The recent 1 day drop sits against a backdrop where the year to date share price return is 19.76% and the 1 year total shareholder return is 113.8%. Momentum still looks more constructive than weak, even if shorter term sentiment...

Interest rate sensitive stocks are back in focus after the Federal Reserve held its policy rate at 3.50 to 3.75% for a fourth straight meeting, while Treasury yields have started to ease from 23-year highs. For investors, that combination can reshape borrowing costs, valuations, and sentiment across the market. This article highlights 3 stocks from our Interest Rate Sensitive Stocks With Potential For Upside in Easing Cycle screener that are closely exposed to the latest Fed signals and...

Mirvac Group (ASX:MGR) has declared an unfranked interim dividend of A$0.048 per share for the six months ended June 30, 2026. This is a key development for investors focused on income from the stock. See our latest analysis for Mirvac Group. Mirvac Group’s A$1.755 share price reflects a mixed picture, with the 30 day share price return up 4.15% while the year to date share price return is down 13.97% and the 1 year total shareholder return down 18.54%. This suggests momentum has softened...

Guidance upgrade puts Redcare Pharmacy stock back in focus Redcare Pharmacy (XTRA:RDC) raised its full year 2026 guidance after reporting stronger than expected Q2 2026 trading, highlighting faster year on year growth in prescription and non prescription sales, especially in Germany. The company now targets total revenue growth of 15% to 17% for 2026, compared with a previous range of 13% to 15%, and guides for an adjusted EBITDA margin between 2.5% and 3.0%. See our latest analysis for...

Insiders who bought US$50.0k worth of Gossamer Bio, Inc. ( NASDAQ:GOSS ) stock in the last year have seen some of their...

Victory Capital Holdings (VCTR) continues to draw attention after a strong past 3 months, with the stock’s total return over that period at around 28%, prompting closer scrutiny of its fundamentals and valuation. See our latest analysis for Victory Capital Holdings. Even after a 28.0% share price return over the past 90 days and a 35.6% share price return year to date, Victory Capital Holdings still sits at US$86.94. The 42.6% one year total shareholder return hints that momentum has been...